{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T05:57:38Z","timestamp":1740981458556,"version":"3.38.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,2]]},"DOI":"10.7759\/cureus.79931","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:26:51Z","timestamp":1740961611000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Coexisting Presentation of Autosomal Dominant Polycystic Kidney Disease With Rapid Deterioration of Renal Function and Neurofibromatosis Type 1"],"prefix":"10.7759","author":[{"given":"Haruna","family":"Noishiki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Komaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Kusaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Tamagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann C","year":"2018","unstructured":"Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJ, Torres VE. Polycystic kidney disease. Nat Rev Dis Primers. 2018, 4:50. 10.1038\/s41572-018-0047-y","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)32782-x","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le Gall E","year":"2019","unstructured":"Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019, 393:919-35. 10.1016\/s0140-6736(18)32782-x","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-023-06680-5","article-title":"Neurofibromatosis type 1 system-based manifestations and treatments: a review","volume":"44","author":"Saleh M","year":"2023","unstructured":"Saleh M, Dib A, Beaini S, et al.. Neurofibromatosis type 1 system-based manifestations and treatments: a review. Neurol Sci. 2023, 44:1931-47. 10.1007\/s10072-023-06680-5","journal-title":"Neurol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115850","article-title":"Current understanding of neurofibromatosis type 1, 2, and schwannomatosis","volume":"22","author":"Tamura R","year":"2021","unstructured":"Tamura R. Current understanding of neurofibromatosis type 1, 2, and schwannomatosis. Int J Mol Sci. 2021, 22:16-8. 10.3390\/ijms22115850","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000065231","article-title":"Coexistence of autosomal dominant polycystic kidney disease and neurofibromatosis: report of a family","volume":"22","author":"Chen MH","year":"2002","unstructured":"Chen MH, Chen KS, Hou JW, Lee CC, Huang JS. Coexistence of autosomal dominant polycystic kidney disease and neurofibromatosis: report of a family. Am J Nephrol. 2002, 22:376-80. 10.1159\/000065231","journal-title":"Am J Nephrol"},{"key":"ref6","article-title":"Malignancy risk in patient with neurofibromatosis and autosomal dominant polycystic kidney disease","volume":"44","author":"Flego V","year":"2003","unstructured":"Flego V, Radojci\u0107 Badovinac A, Plese V, Kapovi\u0107 M, Beg-Zec Z, Zaputovi\u0107 L. Malignancy risk in patient with neurofibromatosis and autosomal dominant polycystic kidney disease. Croat Med J. 2003, 44:485-8.","journal-title":"Croat Med J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2010.01341.x","article-title":"Multiple intercostal neurofibromas in a patient with autosomal dominant polycystic kidney disease","volume":"15","author":"Niemczyk S","year":"2010","unstructured":"Niemczyk S, Niemczyk M, Dylewska M, Go\u0142\u0119biowski M, Niemczyk L, Gom\u00f3\u0142ka M. Multiple intercostal neurofibromas in a patient with autosomal dominant polycystic kidney disease. Nephrology (Carlton). 2010, 15:777-8. 10.1111\/j.1440-1797.2010.01341.x","journal-title":"Nephrology (Carlton)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1321","article-title":"Co-occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2","volume":"8","author":"Peces R","year":"2020","unstructured":"Peces R, Mena R, Mart\u00edn Y, et al.. Co-occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2. Mol Genet Genomic Med. 2020, 8:e1321. 10.1002\/mgg3.1321","journal-title":"Mol Genet Genomic Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal MV","year":"2015","unstructured":"Irazabal MV, Rangel LJ, Bergstralh EJ, et al.. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol. 2015, 26:160-72. 10.1681\/ASN.2013101138","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013040398","article-title":"Strategies targeting cAMP signaling in the treatment of polycystic kidney disease","volume":"25","author":"Torres VE","year":"2014","unstructured":"Torres VE, Harris PC. Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. J Am Soc Nephrol. 2014, 25:18-32. 10.1681\/ASN.2013040398","journal-title":"J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015060648","article-title":"Refining genotype-phenotype correlation in autosomal dominant polycystic kidney disease","volume":"27","author":"Hwang YH","year":"2016","unstructured":"Hwang YH, Conklin J, Chan W, et al.. Refining genotype-phenotype correlation in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2016, 27:1861-8. 10.1681\/ASN.2015060648","journal-title":"J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.01.053","article-title":"How does ADPKD severity differ between family members?","volume":"9","author":"Yeung KC","year":"2024","unstructured":"Yeung KC, Fryml E, Lanktree MB. How does ADPKD severity differ between family members?. Kidney Int Rep. 2024, 9:1198-209. 10.1016\/j.ekir.2024.01.053","journal-title":"Kidney Int Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.66003.x","article-title":"Comparison between siblings and twins supports a role for modifier genes in ADPKD","volume":"66","author":"Persu A","year":"2004","unstructured":"Persu A, Duyme M, Pirson Y, et al.. Comparison between siblings and twins supports a role for modifier genes in ADPKD. Kidney Int. 2004, 66:2132-6. 10.1111\/j.1523-1755.2004.66003.x","journal-title":"Kidney Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/BF00220540","article-title":"Genetics of neurofibromatosis 1 in Japan: mutation rate and paternal age effect","volume":"89","author":"Takano T","year":"1992","unstructured":"Takano T, Kawashima T, Yamanouchi Y, Kitayama K, Baba T, Ueno K, Hamaguchi H. Genetics of neurofibromatosis 1 in Japan: mutation rate and paternal age effect. Hum Genet. 1992, 89:281-6. 10.1007\/BF00220540","journal-title":"Hum Genet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590051654.x","article-title":"Progression of autosomal-dominant polycystic kidney disease in children","volume":"59","author":"Fick-Brosnahan GM","year":"2001","unstructured":"Fick-Brosnahan GM, Tran ZV, Johnson AM, Strain JD, Gabow PA. Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int. 2001, 59:1654-62. 10.1046\/j.1523-1755.2001.0590051654.x","journal-title":"Kidney Int"},{"key":"ref16","unstructured":"The Human Protein Atlas. (2024). Accessed. March 2, 2025: https:\/\/www.proteinatlas.org\/."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2008.06.001","article-title":"The mTOR pathway and its role in human genetic diseases","volume":"659","author":"Rosner M","year":"2008","unstructured":"Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschl\u00e4ger M. The mTOR pathway and its role in human genetic diseases. Mutat Res. 2008, 659:284-92. 10.1016\/j.mrrev.2008.06.001","journal-title":"Mutat Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063317","article-title":"Autosomal dominant polycystic kidney disease: from pathophysiology of cystogenesis to advances in the treatment","volume":"23","author":"Reiterov\u00e1 J","year":"2022","unstructured":"Reiterov\u00e1 J, Tesa\u0159 V. Autosomal dominant polycystic kidney disease: from pathophysiology of cystogenesis to advances in the treatment. Int J Mol Sci. 2022, 23:16-8. 10.3390\/ijms23063317","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3534","article-title":"Neurofibromatosis: types 1 and 2","volume":"34","author":"Borofsky S","year":"2013","unstructured":"Borofsky S, Levy LM. Neurofibromatosis: types 1 and 2. AJNR Am J Neuroradiol. 2013, 34:2250-1. 10.3174\/ajnr.A3534","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.030","article-title":"Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation","volume":"100","author":"Lugthart G","year":"2021","unstructured":"Lugthart G, Jordans CC, de Pagter AP, et al.. Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation. Kidney Int. 2021, 100:906-14. 10.1016\/j.kint.2021.05.030","journal-title":"Kidney Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/342198-a-rare-coexisting-presentation-of-autosomal-dominant-polycystic-kidney-disease-with-rapid-deterioration-of-renal-function-and-neurofibromatosis-type-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:26:53Z","timestamp":1740961613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/342198-a-rare-coexisting-presentation-of-autosomal-dominant-polycystic-kidney-disease-with-rapid-deterioration-of-renal-function-and-neurofibromatosis-type-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,2]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.79931","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,2]]}}}